PROVIDER PROFILE · NPI 1760423347

Roberto IzquierdoMD

EndocrinologySyracuse, NYI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

398

Unique beneficiaries

—

Total services

503

Distinct HCPCS

Medicare payment

$23K

Peer benchmark

Total Medicare services vs. 627 Endocrinology providers in NY — below median (cohort median 837).

PRESCRIBING · PART D · 2024

Total Rx claims

2,423

Beneficiaries

—

Total drug cost

$751K

Distinct drugs

Brand share

49.1%

Top prescribed drugs

Levothyroxine Sodium672 claims

Levothyroxine Sodium244 claims

Metformin Hcl109 claims

Dulaglutide84 claims

Empagliflozin78 claims

QUALITY · MIPS · 2024

Final MIPS score

87.6

Quality

72.0

Cost

75.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.53%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Roberto Izquierdo's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Laboratory Alliance Of Central New York, Llc Clinical Laboratory · Liverpool, NY	31	155
Rolf Grage Diagnostic Radiology · Jacksonville, FL	17	32
CROUSE HEALTH HOSPITAL, INC.	16	52
Jennifer Kelly Internal Medicine · South Burlington, VT	14	38
Rajeev Sharma Internal Medicine · Buffalo, NY	12	31
ST JOSEPHS HOSPITAL HEALTH CENTER	11	32

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history